| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000084 | Mitotic s phase | Affects phenotype | PMID:37584494 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Affects phenotype | PMID:37584494 |
| GO:0002027 | Regulation of heart rate | Affects phenotype | PMID:36706861; PMID:36758786 |
| GO:0002228 | Natural killer cell mediated immunity | Decreases phenotype | PMID:24060340 |
| GO:0002248 | Connective tissue replacement involved in inflammatory response wound healing | Increases phenotype | PMID:29758289 |
| GO:0002381 | Immunoglobulin production involved in immunoglobulin-mediated immune response | Increases phenotype | PMID:1683282; PMID:29758289 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:29758289; PMID:36706861 |
| GO:0002693 | Positive regulation of cellular extravasation | Increases phenotype | PMID:27020608; PMID:28422384 |
| GO:0002859 | Negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | Affects phenotype | PMID:24060340 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:23059809; PMID:39142364 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:23059809; PMID:23059809; PMID:31823256; PMID:29315975; PMID:39142364 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:33259821 |
| GO:0006096 | Glycolytic process | Affects phenotype | PMID:37638564 |
| GO:0006281 | Dna repair | Affects phenotype | PMID:23649840 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:27941166; PMID:28373009 |
| GO:0006606 | Protein import into nucleus | Affects phenotype | PMID:36534342 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:31823256; PMID:33259821 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:24733833; PMID:30395894 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:24733833 |
| GO:0006879 | Cellular iron ion homeostasis | Affects phenotype | PMID:33259821 |
| GO:0006884 | Cell volume homeostasis | Affects phenotype | PMID:36706861 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:22186232; PMID:24140967; PMID:30600586; PMID:36534342; PMID:37584494 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:29315975; PMID:30395894 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:22186232; PMID:23059809 |
| GO:0007507 | Heart development | Affects phenotype | PMID:36758786 |
| GO:0007612 | Learning | Affects phenotype | PMID:30395894 |
| GO:0007613 | Memory | Affects phenotype | PMID:30395894 |
| GO:0008219 | Cell death | Increases phenotype | PMID:17551412; PMID:30395894; PMID:33259821; PMID:39142364 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:25821186; PMID:27339418; PMID:30236600 |
| GO:0008285 | Negative regulation of cell population proliferation | Affects phenotype | PMID:23649840 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:24142868 |
| GO:0010825 | Positive regulation of centrosome duplication | Increases phenotype | PMID:25821186 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:23649840; PMID:28373009; PMID:29860525 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:23059809; PMID:29315975; PMID:31823256; PMID:33259821 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:30236600 |
| GO:0019216 | Regulation of lipid metabolic process | Affects phenotype | PMID:39992237 |
| GO:0019233 | Sensory perception of pain | Increases phenotype | PMID:22236721; PMID:34896366 |
| GO:0030101 | Natural killer cell activation | Affects phenotype | PMID:25157974 |
| GO:0030199 | Collagen fibril organization | Decreases phenotype | PMID:29758289 |
| GO:0030217 | T cell differentiation | Affects phenotype | PMID:1683282 |
| GO:0030534 | Adult behavior | Affects phenotype | PMID:30395894 |
| GO:0030854 | Positive regulation of granulocyte differentiation | Increases phenotype | PMID:27020608 |
| GO:0031394 | Positive regulation of prostaglandin biosynthetic process | Increases phenotype | PMID:27664576 |
| GO:0032609 | Type ii interferon production | Decreases phenotype | PMID:25157974 |
| GO:0032611 | Interleukin-1 beta production | Increases phenotype | PMID:23671638 |
| GO:0032613 | Interleukin-10 production | Increases phenotype | PMID:25157974 |
| GO:0032633 | Interleukin-4 production | Increases phenotype | PMID:23671638; PMID:25157974 |
| GO:0032637 | Interleukin-8 production | Decreases phenotype | PMID:25157974 |
| GO:0032689 | Negative regulation of type ii interferon production | Affects phenotype | PMID:24060340 |
| GO:0032824 | Negative regulation of natural killer cell differentiation | Affects phenotype | PMID:24060340 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:39142364 |
| GO:0034614 | Cellular response to reactive oxygen species | Increases phenotype | PMID:29758289 |
| GO:0034728 | Nucleosome organization | Decreases phenotype | PMID:28937961 |
| GO:0034976 | Response to endoplasmic reticulum stress | Increases phenotype | PMID:24140967 |
| GO:0035491 | Positive regulation of leukotriene production involved in inflammatory response | Increases phenotype | PMID:39992237 |
| GO:0035944 | Perforin production | Decreases phenotype | PMID:24060340 |
| GO:0036336 | Dendritic cell migration | Increases phenotype | PMID:39992237 |
| GO:0040018 | Positive regulation of multicellular organism growth | Decreases phenotype | PMID:28373009 |
| GO:0042113 | B cell activation | Affects phenotype | PMID:25157974 |
| GO:0042310 | Vasoconstriction | Increases phenotype | PMID:30974163; PMID:39067042 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:23359814; PMID:37263556 |
| GO:0043303 | Mast cell degranulation | Increases phenotype | PMID:29758289 |
| GO:0043966 | Histone h3 acetylation | Affects phenotype | PMID:28937961 |
| GO:0043970 | Histone h3-k9 acetylation | Decreases phenotype | PMID:28937961 |
| GO:0043983 | Histone h4-k12 acetylation | Affects phenotype | PMID:28937961 |
| GO:0044065 | Regulation of respiratory system process | Affects phenotype | PMID:23871789 |
| GO:0044154 | Histone h3-k14 acetylation | Decreases phenotype | PMID:28937961 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:31823256; PMID:33233951; PMID:33259821; PMID:36534342; PMID:37584494 |
| GO:0044319 | Wound healing, spreading of cells | Decreases phenotype | PMID:33233951 |
| GO:0045023 | G0 to g1 transition | Affects phenotype | PMID:37584494 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:36116563; PMID:37638564 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:23359814; PMID:37105513 |
| GO:0045821 | Positive regulation of glycolytic process | Increases phenotype | PMID:37105513 |
| GO:0045919 | Positive regulation of cytolysis | Increases phenotype | PMID:27941166 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:22186232 |
| GO:0045953 | Negative regulation of natural killer cell mediated cytotoxicity | Affects phenotype | PMID:24060340 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:31823256; PMID:37638564 |
| GO:0046292 | Formaldehyde metabolic process | Affects phenotype | PMID:30255327 |
| GO:0046293 | Formaldehyde biosynthetic process | Increases phenotype | PMID:31494693 |
| GO:0048266 | Behavioral response to pain | Increases phenotype | PMID:30261224 |
| GO:0050671 | Positive regulation of lymphocyte proliferation | Increases phenotype | PMID:20677212 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:39992237 |
| GO:0061366 | Behavioral response to chemical pain | Increases phenotype | PMID:19027877; PMID:19027877; PMID:29499192; PMID:29499192 |
| GO:0061368 | Behavioral response to formalin induced pain | Increases phenotype | PMID:15315263; PMID:15315263; PMID:28422384; PMID:18164607; PMID:27277137; PMID:27899695; PMID:28422384 |
| GO:0070212 | Protein poly-adp-ribosylation | Affects phenotype | PMID:22479348 |
| GO:0070628 | Proteasome binding | Increases phenotype | PMID:35504338 |
| GO:0070814 | Hydrogen sulfide biosynthetic process | Decreases phenotype | PMID:23359814 |
| GO:0070989 | Oxidative demethylation | Increases phenotype | PMID:8498088 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:36706861 |
| GO:0071169 | Establishment of protein localization to chromatin | Affects phenotype | PMID:36534342 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:33259821; PMID:37584494 |
| GO:0072672 | Neutrophil extravasation | Increases phenotype | PMID:23671638 |
| GO:0072682 | Eosinophil extravasation | Increases phenotype | PMID:23671638 |
| GO:0097531 | Mast cell migration | Increases phenotype | PMID:39992237 |
| GO:0097707 | Ferroptosis | Increases phenotype | PMID:33259821 |
| GO:1900017 | Positive regulation of cytokine production involved in inflammatory response | Increases phenotype | PMID:29860525 |
| GO:1901224 | Positive regulation of nik/nf-kappab signaling | Increases phenotype | PMID:27020608 |
| GO:1902035 | Positive regulation of hematopoietic stem cell proliferation | Increases phenotype | PMID:28373009 |
| GO:1902107 | Positive regulation of leukocyte differentiation | Decreases phenotype | PMID:27020608 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:37584494 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:27339418; PMID:29758289; PMID:30236600 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:28373009 |
| GO:2000318 | Positive regulation of t-helper 17 type immune response | Increases phenotype | PMID:29758289 |
| GO:2000553 | Positive regulation of t-helper 2 cell cytokine production | Increases phenotype | PMID:29758289 |
| GO:2000786 | Positive regulation of autophagosome assembly | Increases phenotype | PMID:24142868 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.